Reynolds-MacKenzie

Reynolds-MacKenzie is a specialist healthcare communications and public relations agency that serves the global pharmaceutical and biotechnology industries. Founded in 2004, the agency provides strategic consultancy, media relations, patient advocacy, and corporate communications services. It is well-regarded for its expertise in managing complex product launches and developing impactful disease awareness campaigns. The firm works across a broad range of therapeutic areas, including oncology, rare diseases, and vaccines. In 2011, the company was acquired by Open Health, where it continues to operate as a core component of the group's communications and public relations offering. The agency has received multiple industry accolades for its creative approach and strategic execution in healthcare PR.